Hau Giang Pharmaceutical Joint Stock Company (DHG)’s Board of Directors (BOD) has appointed Nguyen Chi Thanh as the new chairman of the company, starting October 26.

The appointment was made following the extraordinary general meeting on October 25.

Thanh is currently deputy general director of the State Capital Investment Corporation (SCIC), chairman of the Domesco Medical Import-Export Joint Stock Corporation, vice chairman of the Tien Phong Plastic Joint Stock Company, member of the Military Commercial Joint Stock Bank’s BoD and member of Viet Nam Television Tower Company’s BoD.

He replaced Hoang Nguyen Hoc, representative of SCIC Capital, because Hoc reached the retirement age according to current regulations. Hoc was also dismissed from the company’s BoD.

Recently, Hau Giang Pharmaceutical has witnessed significant personnel-related changes. Notably, Pham Thi Viet Nga resigned from the position of general director but still continues to be a member of the BoD to participate in the company’s strategy management.

In the first nine months of 2017, the company reported net sales of VND2.71 trillion and after-tax profit of VND498 billion, a year-on-year increase of four per cent and six per cent, respectively. With these results, the company has fulfilled 62 per cent of its revenue and profit target. — VNS